Clinical Trials
5
Active:0
Completed:2
Trial Phases
3 Phases
Phase 3:2
Phase 4:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (50.0%)Not Applicable
1 (25.0%)Phase 4
1 (25.0%)Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder
Phase 3
Completed
- Conditions
- SchizophreniaSchizoaffective DisorderSchizophreniform DisorderPsychosis NOS
- Interventions
- Drug: Placebo
- First Posted Date
- 2017-02-06
- Last Posted Date
- 2021-10-08
- Lead Sponsor
- Iris Sommer
- Target Recruit Count
- 110
- Registration Number
- NCT03043820
- Locations
- 🇳🇱
UMC Utrecht, Utrecht, Netherlands
Understanding Hallucinations (Part II)
- Conditions
- Hallucinations
- First Posted Date
- 2015-06-03
- Last Posted Date
- 2016-10-26
- Lead Sponsor
- Iris Sommer
- Target Recruit Count
- 240
- Registration Number
- NCT02460965
- Locations
- 🇳🇱
UMC Utrecht, Utrecht, Netherlands
Simvastatin Addition for Patients With Recent-onset Schizophrenia
Phase 3
Completed
- Conditions
- Schizoaffective DisorderSchizophreniform DisorderPsychosis NOSSchizophrenia
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-12-03
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Iris Sommer
- Target Recruit Count
- 121
- Registration Number
- NCT01999309
- Locations
- 🇳🇱
University Medical Center Groningen, Groningen, Netherlands
🇳🇱University Medical Center Utrecht, Utrecht, Netherlands
Transcranial Direct Current Stimulation as Treatment for Auditory Hallucinations
Not Applicable
- Conditions
- Hearing DisordersPersonality DisordersStress Disorders, Post-TraumaticPsychotic DisordersMood Disorders
- First Posted Date
- 2013-11-06
- Last Posted Date
- 2017-05-03
- Lead Sponsor
- Iris Sommer
- Target Recruit Count
- 62
- Registration Number
- NCT01977521
- Locations
- 🇳🇱
UMC, Utrecht, Netherlands
Effect of Methylphenidate on Connectivity
Phase 4
Withdrawn
- Conditions
- Attention Deficit Hyperactivity Disorder
- Interventions
- Other: Placebo
- First Posted Date
- 2013-01-09
- Last Posted Date
- 2014-02-26
- Lead Sponsor
- Iris Sommer
- Registration Number
- NCT01764672
- Locations
- 🇳🇱
UMC Utrecht, Utrecht, Netherlands
News
No news found